Introduction: Cutting-Edge Cancer Treatment and the Systems That Support It1.1 Becoming a Global Leader Through a "Technology-First" Approach1.2 "Insured Treatment" and "Advanced Medical Care": The Two HurdlesChapter 1: Japan - World-Class Technology and a System That Can't Fully Utilize Itthe cancer cells while minimizing damage to surrounding healthy tissue. Due to this high precision, particle beam therapy is expected to be particularly effective for cancers near critical organs like the brain and spinal cord, as well as for treating pediatric cancers in growing children. However, this therapy requires extremely expensive equipment and specialized personnel. Therefore, a key challenge for every country is how to make this superior treatment equitably accessible to all while sustaining it within the constraints of national healthcare budgets. This report will compare Japan, the United States, and Germany through the lens of particle beam therapy, examining the differences in their healthcare system philosophies and the challenges facing Japan. This is the result of a national science and technology policy that has emphasized research and development. Japan's development has been characterized by a "technology-first" approach, where incredible technological advancements are first made, and then applications in medicine are sought.patient. This system reflects a cautious stance, where new, expensive treatments are not immediately covered by insurance but are first implemented as "Advanced Medical Care" to accumulate a track record and verify their efficacy and safety. However, this has created an equity issue, where the ability to receive treatment heavily depends on an individual's financial status or whether they have private insurance.Chihiro Ito Radiation therapy, one of the pillars of cancer treatment, is constantly evolving. Among its advancements, "particle beam therapy" has garnered particular attention. Conventional radiation therapy using X-rays has a significant drawback: the radiation energy is strongest near the body's surface and passes through the body, damaging not only cancer cells but also healthy cells in its path. In contrast, particle beam therapy has a distinct physical property where the particle beam stops at a specific point within the body, releasing its maximum energy at that instant. This point of maximum energy release is called the "Bragg peak." By precisely aligning this "Bragg peak" with the location of cancer cells, it becomes possible to selectively attack only Particle beam therapy in Japan has two facets: it possesses world-leading technology, yet it has a system that fails to fully leverage that technology. Japan has numerous particle beam therapy facilities. There are two types: "proton beam therapy," which uses particles called protons, and "heavy-ion therapy," which uses heavier carbon ions. Heavy-ion therapy is expected to have a more potent effect on specific cancers, and Japan is a true leader in this field, possessing more than half of the world's facilities.Under Japan's public medical insurance system, particle beam therapy is divided into two categories: "Insured Treatment" and "Advanced Medical Care." Insured Treatment: Only a very limited number of cancers, such as pediatric and bone cancers, are covered. In this case, the patient's co-payment is only a fraction of the treatment cost (10-30%).Advanced Medical Care: This applies to cancers other than those mentioned above. In this case, the technology fee (approximately 3 million JPY) is entirely borne by the Graduate School of Tokyo University of Science, Japan10Challenges in Healthcare Systems for Particle Beam Therapy: An Analysis of Japan and International Comparison
元のページ ../index.html#11